Glaxo SmithKline is the world’s leading research based pharmaceuticals company. It was formed on December 27, 2000 as a result of merger of two leading international organizations viz.,
GlaxoWellcome and Smithkline Beecham.

The company is working hard to improve the quality of the human life by enabling people to do more, feel better and live longer. It believes that there is no achievement without integrity. The company has its headquarters in UK with operations based in USA, and has 85 manufacturing sites in over 37 countries. The company has combined sales of over 20 billion pounds, market share of about 7%, and intellectual property of more than 100,000 employees worldwide.
Out of these 100,000 employees, approximately 35% are in manufacturing units, 16% are in R&D, and 40% are in sales and marketing. The manufacturing plants of the company in India are located in Nabha, Rajahmundry and Sonepat, and have employee strength of about 2700.

GSK Consumer healthcare Ltd. and GSK Pharmaceuticals Ltd. are the two businesses of GSK in India with headquarters at Gurgaon, Haryana. Its products include:

1. GI & Analgesics: Crocin, and Eno
2. Rubefacients: Iodex
3. Nutritional: Boost, Horlicks, Viva, and Maltova

Contact Address:
GlaxoSmithKline Consumer Healthcare,
DLF Plaza Tower,
DLF Phase I, Gurgaon – 122002
Haryana, India.
Ph: 0124-2540700/ 5057700
Fax: 0124-2540720/2540721
e-mail: contact.4.qsk@qsk.com

Quarterly Results of Glaxo

Quarterly Results (Rs. in Millions)
Dec 2006 (3rd quarter) Sept 2006(2nd quarter) Dec 2005 (3rd quarter)
Sales Turnover 3488.9 4327.9 3430.5
Other Income 299.4 253.6 209.7
Total Income 3788.3 4581.5 3640.2
Total Expenditure 2674.9 3045.2 2767.9
Operating Profit 1113.4 1536.3 872.3
Interest 0 0 0
Gross Profit 1113.4 1536.3 872.3
Depreciation 41.1 40.7 44.1
Tax 390.7 504.9 315.8
Reported PAT 677.9 2854.3 423.8

*Source: economictimes.indiatimes.com

Quarterly Results (in %)
% Change(Over Sep 2006) % Change (Over Dec 2005)
Sales Turnover -19.39 1.7
Other Income 18.06 42.78
Total Income -17.31 4.07
Total Expenditure -12.16 -3.36
Operating Profit -27.53 27.64
Interest 0 0
Gross Profit -27.53 27.64
Depreciation 0.98 -6.8
Tax
Reported PAT -76.25 59.96

*Source: economictimes.indiatimes.com

Annual Results of Glaxo

Annual Unaudited Results (Rs. in Millions)
(12 Months) (12 Months) % Changes
Sales Turnover 16775.70 15758.90 6.45
Other Income 958.4 656.4 46.01
Total Income 17734.10 16415.30 8.03
Total Expenditure 12016.10 11478.90 4.68
Operating Profit 5718.00 4936.40 15.83
Interest 0 0
Gross Profit 5718.00 4936.40 15.83
Depreciation 158.5 157.3 0.76
Tax 1942.30 1716.30 13.17
Reported PAT 5455.10 520.80 8.65

*Source: economictimes.indiatimes.com